This site has been archived on
Sixth FrameWork Programme
Legal Notice
Life sciences, genomics and biotechnology for health
2002-2006 You are here: Home Page | Thematic Areas | Application of knowledge and technologies in the field of genomics and biotechnology for health
Work Programme
International Cooperation
Innovation and SMEs
Useful Links
What's New?
Go to the Sixth FrameWork Programme Service on CORDIS

Application of knowledge and technologies in the field of genomics and biotechnology for health

Objectives : to foster the competitiveness of Europe's biotechnology industry in developing new diagnostic, disease prevention and therapeutic tools that contribute to better and more cost-efficient health care.

Approach : Support for technological platforms in which academic and industrial partners collaborate in multidisciplinary approaches to develop these tools, using cutting- edge technologies arising from genomic research.

Innovative Medicines Initiative

Research Action Headings with linked call topics:

General considerations:
Support will be aimed in particular towards innovative research in genomic start-ups and research-based SMEs. Project consortia should integrate SMEs as full participants and make the innovation aspects visible through clear dissemination and exploitation plans.

Ethical and regulatory issues should be taken into account, and experts, patients, and the public involved and consulted as appropriate, in an effort to promote socially responsible choices, public acceptance and an efficient exploitation of the new technologies being developed.

Relevant publications:

  • 100 Technology Offers stemming from EU Biotechnology RTD results (Download in PDF )
  • Today's research for tomorrow's treatments - Cell factory research projects with clinical relevance, download from CORDIS Quality of Life Publications

Human Frontier Science Programme (HFSP)

Considering the Community's interest in the Human Frontier Science Programme (HFSP) and the commonality of objectives with this theme, an annual contribution, which will provide the possibility for non G8 Member States to fully benefit from the programme, will be made available for the whole duration of FP6.

Further information may be had at (email removed)